COMPASS PATHWAYS PLC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
COMPASS PATHWAYS PLC (CMPS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 89.42% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-03-24
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 87.57%, a 0.52% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-09-30 was 87.59%, a 7.60% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-06-30 was 91.82%, a 13.12% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 87.12%, a 8.63% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 89.42%, a 3.92% increase from fiscal 2024.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 86.05%, a 1.47% decline from fiscal 2023.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 87.33%, a 8.14% increase from fiscal 2022.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 80.76%, a 19.89% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 89.42% 10-K · filed 2026-03-24 | |||
| 2024-12-31 | 86.05% 10-K · filed 2026-03-24 | |||
| 2024-03-31 | 87.57% 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | 87.33% 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 87.59% 10-Q · filed 2023-11-02 | 87.67% 10-Q · filed 2023-11-02 | ||
| 2023-06-30 | 91.82% 10-Q · filed 2023-08-03 | 87.70% 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | 87.12% 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 80.76% 10-K · filed 2024-02-29 | |||
| 2022-09-30 | 81.40% 10-Q · filed 2023-11-02 | 80.72% 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | 81.17% 10-Q · filed 2023-08-03 | 80.29% 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | 80.20% 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 67.36% 10-K · filed 2024-02-29 | |||
| 2021-09-30 | 66.90% 10-Q · filed 2022-11-03 | 67.20% 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | 67.40% 10-Q · filed 2022-08-04 | 67.70% 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | 67.80% 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 66.10% 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 66.90% 6-K · filed 2021-11-09 | 66.00% 6-K · filed 2021-11-09 | ||
| 2020-06-30 | 66.10% 6-K · filed 2021-08-11 | 65.79% 6-K · filed 2021-08-11 | ||
| 2019-12-31 | 63.40% 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |